Zdrowie i gospodarka · 07/12/2006

FDA Publishes Companion Proposed Rule to Remove Essential Use Designations for Certain Ozone-Depleting Substances

The Food and Drug Administration (FDA) is publishing a proposed rule to remove essential use designations for certain ozone-depleting substances used in oral pressurized metered-dose inhalers (MDIs), as required by the Clean Air Act.